Skin Script blemish spot treatment recalled for failing stability specifications
Skin Script Blemish Spot Treatment containing 1% salicylic acid is being recalled after it failed stability specifications. The action covers 28,163 bottles.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for an out-of-specification stability result, a product-quality failure creating risk of harm, with no injuries reported in the source.
Plain-English summary
Skin Script Blemish Spot Treatment (salicylic acid) 1%, in 0.5 fl oz (15 ml) bottles, UPC 6 10563 13873 9, is being recalled by Skin Script of Chandler, Arizona. The action covers 28,163 bottles.
The stated reason is that the product failed stability specifications. Stability testing confirms that a product stays within its approved specification across its shelf life, so a failure means the product may not meet specification for the labelled period. The FDA classified the action as Class II.
Affected lots are 4228D2 and 4229D1 (expiry 07/31/2026) and 5147D2 (expiry 04/30/2027). Distribution was US nationwide.
Consumers who have an affected lot should stop using it and contact the retailer or the firm about a refund or replacement.
The recalled product
- Product
- Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9.
- Category
- Drug — Topical acne treatment
- Affected units
- 28,163
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot#: 4228D2
- 4229D1
- Exp.: 07/31/2026 Lot#: 5147D2
- Exp.: 04/30/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Island Kinetics, Inc. d.b.a. CoValence Laboratories
See all →- ModerateSkin Rehab calming hydrocortisone balm recalled as a subpotent drug
FDA (Drugs) · 2026-04-22
- Moderateglo Skin Beauty Remedy Gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
- ModerateRhonda Allison calming skin gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
- LowPCA Skin Blemish Control Bar Recalled for High Salicylic Acid Content
FDA (Drugs) · 2020-01-08
Same hazard · failed stability
See all →- ModerateBioSpectra Recalls Tris/Tromethamine API Due to Failed Stability Specifications
FDA (Drugs) · 2026-10-14
- ModeratePred Mild prednisolone eye suspension failed stability specifications
FDA (Drugs) · 2026-06-03
- HighZilretta Injectable Drug Recalled for Failed Stability Specifications
FDA (Drugs) · 2024-06-19
- HighSpecialty Process Labs Recalls Thyroid USP Drug Ingredient for Failed Stability
FDA (Drugs) · 2024-04-24
- SeverePrescription Birth Control Tablets Recalled for Failed Stability Testing
FDA (Drugs) · 2023-08-09
Similar recalls
- LowSun Pharmaceutical Recalls Azelastine HCl Nasal Spray for Stability Test Failure
FDA (Drugs) · 2018-02-21
- LowLife Brand Acne Treatment Stick Recalled for Failed Assay
FDA (Drugs) · 2018-03-14
- LowUltra Seal Recalls Pain Relief Tablets Due to Stability Failures
FDA (Drugs) · 2020-08-26
- LowPCA Skin Blemish Control Bar Recalled for High Salicylic Acid Content
FDA (Drugs) · 2020-01-08
- ModerateClonidine HCl USP Recalled Due to Missing Stability Data
FDA (Drugs) · 2018-02-28
- HighSLMD benzoyl peroxide spot treatment recalled over benzene contamination
FDA (Drugs) · 2026-04-22